(Q34483036)

2 August 2017

1 reference

title

Recent updates in hepatitis vaccination and the prevention of hepatocellular carcinoma (English)

1 reference

2 August 2017

2

Ding-Shinn Chen

1 reference

2 August 2017

Jia-Horng Kao

1

1 reference

PubMed ID

11774275

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

International Journal of Cancer

2 August 2017

1 reference

2 August 2017

97

1 reference

2 August 2017

3

1 reference

2 August 2017

269-271

1 reference

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

2 August 2017

1 reference

A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china

21 January 2018

1 reference

Nationwide vaccination: a success story in Taiwan.

21 January 2018

1 reference

Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization

21 January 2018

1 reference

Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program

21 January 2018

1 reference

Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan.

21 January 2018

1 reference

Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients

21 January 2018

1 reference

Effect of hepatitis B virus mutants on efficacy of vaccination

21 January 2018

1 reference

Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus

21 January 2018

1 reference

Hepatitis B virus mutants and efficacy of vaccination

21 January 2018

1 reference

Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group

21 January 2018

1 reference

Hepatitis B vaccination and the risk of multiple sclerosis

21 January 2018

1 reference

Are booster immunisations needed for lifelong hepatitis B immunity?

21 January 2018

1 reference

Public health measures to control hepatitis B virus infection in the developing countries of the Asia-Pacific region

21 January 2018

1 reference

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

21 January 2018

1 reference

Vaccination of chimpanzees against infection by the hepatitis C virus

21 January 2018

1 reference

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

21 January 2018

1 reference

Mixed infections of hepatitis C virus as a factor in acute exacerbations of chronic type C hepatitis

21 January 2018

1 reference

Superinfection by homotypic virus in hepatitis C virus carriers: studies on patients with post-transfusion hepatitis

21 January 2018

1 reference

The molecular biology of hepatitis delta virus

21 January 2018

1 reference

DNA-Based immunization produces Th1 immune responses to hepatitis delta virus in a mouse model

21 January 2018

1 reference

Transmission of hepatitis C virus in Asia: past and present perspectives

21 January 2018

1 reference

The treatment of chronic viral hepatitis

21 January 2018

1 reference

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa

21 January 2018

1 reference

Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis.

21 January 2018

1 reference

Superinfection of heterologous hepatitis C virus in a patient with chronic type C hepatitis

21 January 2018

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

From hepatitis to hepatoma: lessons from type B viral hepatitis

21 January 2018

1 reference

Primary prevention of hepatocellular carcinoma in developing countries.

21 January 2018

1 reference

Rising incidence of hepatocellular carcinoma in the United States

21 January 2018

1 reference

Rationale for the infant and adolescent vaccination programmes in Italy

21 January 2018

1 reference

Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen

21 January 2018

1 reference

Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction

21 January 2018

1 reference

Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls

21 January 2018

1 reference

Hepatocellular carcinoma in patients with HCV

21 January 2018

1 reference

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

21 January 2018

1 reference

Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.1608

1 reference

2 August 2017

1 reference

PubMed ID

11774275